Not Yet Recruiting
The Efficacy and Safety of Sonrotoclax, Zanubrutinib Combined With Obinutuzumab in MCL
NCT07548255
- Conditions
- Intermediate-to-High-Risk Mantle Cell Lymphoma, the Efficacy and Safety
- Locations
-
- Shanghai Ruijin Hospital Shanghai, Shanghai Municipality, China